Theranos123 則有來源的主張、爭議事實與證據

Topic summary

Elizabeth Holmes, Theranos, and the claims that built and then broke the blood-testing story.

Key research questions

• Voided and Inaccurate Test Results
• Data Manipulation and Quality Control Issues
• False Patient Results and Harm
• Sample Dilution Practices
• Siemens Machine Issues
• Ian Gibbons' Suicide
• CMS Findings and Sanctions
• Use of Commercial Analyzers

Important claims and supporting citations

• On December 29, 2023, the HHS Inspector General excluded Elizabeth Holmes from participation in all federal health-care programs for 90 years. An administrative law judge upheld this exclusion on April 25, 2025, and the HHS Departmental Appeals Board subsequently affirmed it in 2026.

  • https://www.hhs.gov/about/agencies/dab/decisions/board-decisions/2026/board-dab-3222/index.html
  • https://case-law.vlex.com/vid/walgreen-co-v-theranos-890950588

• HHS rejected Elizabeth Holmes's argument that her acquittal on patient-related counts precluded exclusion for an offense connected with health-care delivery, holding that investor fraud concerning Theranos’s blood-testing products and services had a "common sense connection or nexus" to health-care delivery.

  • https://www.hhs.gov/about/agencies/dab/decisions/board-decisions/2026/board-dab-3222/index.html

• A Walgreens representative testified that the planned rollout of Theranos services was reduced partly because a high proportion of collections required venipuncture rather than finger sticks.

  • https://corporate.walgreens.com/news-and-stories/press-releases/2016/walgreens-terminates-relationship-with-theranos-will-be-closing-operations-at-all-40-theranos-wellness-centers-in-arizona/

• Theranos generated no revenue in 2012 or 2013, while recording net losses of approximately $57 million in 2012 and $92 million in 2013, according to testimony from corporate controller Han Spivey.

  • https://corporate.walgreens.com/news-and-stories/press-releases/2016/walgreens-terminates-relationship-with-theranos-will-be-closing-operations-at-all-40-theranos-wellness-centers-in-arizona/

• Theranos operated two separate lab systems: one for demonstrations to investors/partners using the Edison device, and another for actual patient results using commercial analyzers.

  • https://medium.com/@sb/theranos-more-than-a-pin-prick-2f1b4b0e5c9a

• A 2012 amendment to the Walgreens contract stipulated that Theranos would establish a training and certification program for Walgreens technicians to provide laboratory patient services under Theranos’s direction, with Theranos supplying collection tubes, lancets/finger-stick devices, bandages, and related materials.

  • https://corporate.walgreens.com/news-and-stories/press-releases/2016/walgreens-terminates-relationship-with-theranos-will-be-closing-operations-at-all-40-theranos-wellness-centers-in-arizona/

• Theranos purchased commercial Siemens ADVIA analyzers through a secret subsidiary to avoid suspicion from Siemens because their own technology failed.

  • https://scholarworks.uark.edu/cgi/viewcontent.cgi?article=1109&context=acctuht

• Sunny Balwani ordered lab staff to run federal proficiency testing samples exclusively on third-party commercial analyzers rather than the Edison to maintain CLIA lab certification.

  • https://medium.com/@sb/theranos-more-than-a-pin-prick-2f1b4b0e5c9a

Competing explanations

• Theranos voided all Edison results from 2014 and 2015 and issued tens of thousands of corrected reports.

• Theranos reported a total of 31,000 voided or corrected tests, which is materially lower than the 50,000–60,000 estimate later provided by Das.

• Theranos claimed its company-wide voiding/correction of less than 1% of results was done "out of an abundance of caution" and that it stood behind the other 99% with no plans for further corrections.

• If $6.9 million is the correct 2013 cash trough, the implied runway at $2 million/week is approximately 3.5 weeks, which is roughly half the 7.5 weeks stated in the parent claim.

• Theranos's corporate controller, Yam/Spivey, testified that the company made no revenue in 2012 and 2013 and was burning through $2 million per week in 2013, leading to cash getting "a bit tight."

• Prosecutors told the Balwani jury that Theranos was down to $6.9 million in cash in 2013, which is less than half the ~$15 million asserted in the parent claim.

Outstanding questions

• The miniLab, introduced in 2016 to replace the Edison, was essentially a robotic glue gun paired with mini test tubes.
• Theranos voided all Edison results from 2014 and 2015 and issued tens of thousands of corrected reports.
• Elizabeth Holmes personally admitted under oath to altering documents by adding Pfizer and Schering-Plough logos to Theranos-authored reports.
• Later evidence indicates that approximately 50,000 to 60,000 individual Edison test results were voided by Theranos, not necessarily 50,000 to 60,000 patients or laboratory reports.
• More than 10% of Theranos' test results given to Arizonans between 2013 and 2016 were ultimately voided or corrected.
• Internal documents and whistleblower testimonies indicated data manipulation to hide inaccuracies in Theranos' test results.
• The miniLab's miniaturized centrifuge was known to occasionally explode.
• Erika Cheung reported that Theranos supervisors instructed staff to delete or disregard outlier quality control data points to make runs pass.